Reportlinker Adds Triple Analysis: Breast Cancer, Lymphoma and Pancreatic Cancer
Reportlinker Adds Triple Analysis: Breast Cancer, Lymphoma and Pancreatic Cancer
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Organizations Tags: adds, Analysis, breast, cancer, Lymphoma, pancreatic, Reportlinker, Triple
CVS Caremark Part I – Industry and Business Analysis
CVS Caremark Part I – Industry and Business Analysis
By Rishi Gosalia. Summary: CVS Caremark ( CVS ) is a leader in the pharmaceutical services industry. It was formed in 2007 as a result of the merger of the nation’s largest retail pharmacy chain, CVS, and the second largest prescription benefits manager, (PBM) Caremark Rx. Read more » »
Read more on Guru Focus
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
iCAD, Inc. , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology’s annual meeting being held in Vienna, Austria from March 3 – 7, 2011.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Treatment Tags: 2011, Analysis, breast, cancer, colon, Detection, Features, iCAD, Image, prostate, Solutions
New Analysis from Phase 2b Study Reinforces Favorable Survival Data Observed with FOLOTYN® Relative to Erlotinib in …
New Analysis from Phase 2b Study Reinforces Favorable Survival Data Observed with FOLOTYN® Relative to Erlotinib in …
Allos Therapeutics, Inc. today announced the presentation of further data from the Company’s randomized, international Phase 2b investigational study of FOLOTYN® relative to erlotinib in patients with Stage IIIB/IV non-small cell lung cancer at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Analysis, Data, Erlotinib, Favorable, FOLOTYN®, From, Observed, Phase, Reinforces, relative, Study, Survival
Research and Markets: Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis 2010 out Now for Those Operating …
Research and Markets: Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis 2010 out Now for Those Operating …
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/02fd1b/triple_analysis_b) has announced the addition of the “Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis” report to their offering. This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of …
Read more on Business Wire